FDA Wants Launch Promotions Early for Accelerated Approval Drugs

Washington Drug Letter
A A
Drugmakers with drugs or biologics under FDA review for accelerated approval should submit promotional materials to the agency while the drug is under review if they plan to use the launch materials within 120 days of approval.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00